OSYRICIN

This brand name is authorized in Nigeria.

Active ingredients

The drug OSYRICIN contains one active pharmaceutical ingredient (API):

1	Erythromycin UNII LXW024X05M - ERYTHROMYCIN STEARATE
	Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism.
	Read more about Erythromycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5324	Tablet	Osyricin Tablets TAB 500 mg 1 x 10's (in PVC-Alu blister)	Tablets White colored, oval shaped, biconvex, film coated tablet having break line on one side and plain on other side of each tablet 145 RNW-PP-118621 OSYRICIN TABLETS ERYTHROMYCIN STEARATE BP 500MG EACH TABLET CONTAINS ERYTHROMYCIN STEARATE BP 500MG EXCIPIENTS Maize starch Croscarmellose sodium Povidone, Talc Magnesium stearate Tablet coating B4-5324 Drugs Imported Products 1X10 Prescription Only Medicine (POM) 9/1/2022 OSSY ADAMU PHARMACEUTICAL COMPANY LIMITED, 1, UMMUNA STREET, ONITSHA 8062789365 ossyadamu2019@outlook.com M/S MAXHEAL LABORATORIES PVT. LTD , 2-7/80-85, SURSEZ, SACHIN, GUJARAT, INDIA, India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA01	Erythromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5324